AVROBIO, Inc. AVRO NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

Il y a eu 50 transactions d'initiés récentes enregistrées pour AVROBIO, Inc. (AVRO), dont 39 achats et 9 ventes. Le total des achats d'initiés s'élève à $2.93M et le total des ventes d'initiés à $303.13K.

Les initiés notables ayant une activité récente comprennent Leonard Braden Michael, Avruch Steven, Ostrowski Erik. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — AVRO

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2024-05-14	Leonard Braden Michael	10 Percent Owner	Achat Informatif	296,882	$1.30	$385.95K	4,768,262
2024-05-13	Leonard Braden Michael	10 Percent Owner	Inconnu	-	-	-	4,471,380
2024-05-13	Leonard Braden Michael	10 Percent Owner	Achat Informatif	253,700	$1.24	$313.32K	4,255,327
2024-05-13	Leonard Braden Michael	10 Percent Owner	Cession	-	-	-	400,000
2024-02-05	Avruch Steven	Chief Legal Officer	Retenue Fiscale RSU	10,812	$1.20	$13K	22,022
2024-02-05	Ostrowski Erik	Interim CEO, President and CFO	Retenue Fiscale RSU	13,099	$1.20	$15.74K	29,285
2024-02-05	Ridha Essra	Chief Medical Officer	Retenue Fiscale RSU	16,953	$1.20	$20.35K	15,881
2024-02-05	Golipour Azadeh	Chief Technology Officer	Retenue Fiscale RSU	12,232	$1.20	$14.7K	55,872
2024-02-01	Avruch Steven	Chief Legal Officer	Exercice d'Options	32,834	-	-	32,834
2024-02-01	Ostrowski Erik	Interim CEO, President and CFO	Exercice d'Options	40,084	-	-	42,384
2024-02-01	Ridha Essra	Chief Medical Officer	Exercice d'Options	32,834	-	-	32,834
2024-02-01	Golipour Azadeh	Chief Technology Officer	Exercice d'Options	37,334	-	-	68,104
2023-07-01	Ostrowski Erik	Interim CEO, President and CFO	Attribution de RSU	70,000	-	-	70,000
2023-06-12	Golipour Azadeh	Chief Technology Officer	Retenue Fiscale RSU	111	$1.21	$133.76	30,770
2023-06-06	Donenberg Phillip B.	Director	Attribution de RSU	17,643	$1.09	$19.23K	17,643
2023-06-06	Clark Ian T	Director	Attribution de RSU	17,643	$1.09	$19.23K	17,643
2023-06-06	Booth Bruce	Director	Attribution de RSU	17,643	$1.09	$19.23K	17,643
2023-06-06	Farfel Gail M	Director	Attribution de RSU	17,643	$1.09	$19.23K	17,643
2023-06-06	Vickers Philip J.	Director	Attribution de RSU	17,643	$1.09	$19.23K	17,643
2023-06-06	Jenkins Annalisa	Director	Attribution de RSU	17,643	$1.09	$19.23K	17,643
2023-06-06	Paige Christopher	Director	Attribution de RSU	17,643	$1.09	$19.23K	17,643
2023-02-08	Petersen Deanna M	Chief Business Officer	Attribution de RSU	86,667	-	-	86,667
2023-02-08	Mackay Geoffrey	President & CEO	Attribution de RSU	300,667	-	-	300,667
2023-02-08	Avruch Steven	Chief Legal Officer	Attribution de RSU	131,333	-	-	131,333
2023-02-08	Ostrowski Erik	Chief Financial Officer	Attribution de RSU	160,333	-	-	160,333
2023-02-08	Ridha Essra	Chief Medical Officer	Attribution de RSU	131,333	-	-	131,333
2023-02-08	Golipour Azadeh	Chief Technology Officer	Attribution de RSU	149,333	-	-	149,333
2023-01-24	Mackay Geoffrey	President & CEO	Exercice d'Options (Vente)	45,999	-	-	-
2022-12-28	Mackay Geoffrey	President & CEO	Don (Donné)	245,123	-	-	142,013
2022-12-23	Mackay Geoffrey	President & CEO	Exercice d'Options (Vente)	142,013	-	-	-
2022-12-08	Petersen Deanna M	Chief Business Officer	Attribution de RSU	111,500	-	-	111,500
2022-12-08	Mackay Geoffrey	President & CEO	Attribution de RSU	388,000	-	-	388,000
2022-12-08	Avruch Steven	Chief Legal Officer	Attribution de RSU	169,500	-	-	169,500
2022-12-08	Ostrowski Erik	Chief Financial Officer	Attribution de RSU	221,000	-	-	221,000
2022-12-08	Ridha Essra	Chief Medical Officer	Attribution de RSU	183,000	-	-	183,000
2022-12-08	Golipour Azadeh	Chief Technology Officer	Attribution de RSU	165,000	-	-	165,000
2022-06-08	Donenberg Phillip B.	Director	Attribution de RSU	17,478	-	-	17,478
2022-06-08	Clark Ian T	Director	Attribution de RSU	17,478	$1.06	$18.53K	17,478
2022-06-08	Booth Bruce	Director	Attribution de RSU	17,478	$1.06	$18.53K	17,478
2022-06-08	Farfel Gail M	Director	Attribution de RSU	17,478	$1.06	$18.53K	17,478
2022-06-08	Vickers Philip J.	Director	Attribution de RSU	17,478	$1.06	$18.53K	17,478
2022-06-08	Jenkins Annalisa	Director	Attribution de RSU	17,478	-	-	17,478
2022-06-08	Paige Christopher	Director	Attribution de RSU	17,478	$1.06	$18.53K	17,478
2022-06-08	Golipour Azadeh	Chief Technology Officer	Cession	130,000	$1.84	$239.2K	-
2022-02-02	Petersen Deanna M	Chief Business Officer	Attribution de RSU	80,000	$1.84	$147.2K	80,000
2022-02-02	Mackay Geoffrey	President & CEO	Attribution de RSU	328,500	$1.84	$604.44K	328,500
2022-02-02	Avruch Steven	Chief Legal Officer	Attribution de RSU	90,000	$1.84	$165.6K	90,000
2022-02-02	Ostrowski Erik	Chief Financial Officer	Attribution de RSU	145,000	$1.84	$266.8K	145,000
2022-02-02	Ridha Essra	Chief Medical Officer	Attribution de RSU	75,000	$1.84	$138K	75,000
2021-11-01	Ridha Essra	Chief Medical Officer	Attribution de RSU	120,000	$5.67	$680.4K	120,000

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration